Johnson Bankole A, Swift Robert M, Addolorato Giovanni, Ciraulo Domenic A, Myrick Hugh
Department of Psychiatric Medicine, The University of Virginia, Charlottesville, Virginia 22908-0623, USA.
Alcohol Clin Exp Res. 2005 Feb;29(2):248-54. doi: 10.1097/01.alc.0000153542.10188.b0.
This article highlights the proceedings of a symposium presented at the 27th Annual Scientific Meeting of the Research Society on Alcoholism in Vancouver, British Columbia, Canada, June 29, 2004. The organizers and co-chairs were Bankole A. Johnson, MD, PhD, and Robert M. Swift, MD, PhD. The presentations included (1) Introduction, by Bankole A. Johnson; (2) Safety, Tolerability, and Efficacy of gamma-Hydroxybutyric Acid and Baclofen in the Treatment of Alcohol Addiction, by Giovanni Addolorato; (3) Safety of Gabapentin in Treating Alcoholism, by Hugh Myrick; (4) New Data on the Safety and Effectiveness of Topiramate in the Treatment of Alcohol Dependence, by Bankole A. Johnson; (5) Evaluating the Risk of Benzodiazepine Prescription to Alcohol-Dependent Individuals, by Domenic A. Ciraulo; and (6) Safety and Efficacy of GABAergic Agents in Treating Alcoholics: Discussion, by Robert M. Swift.
本文重点介绍了2004年6月29日在加拿大不列颠哥伦比亚省温哥华举行的第27届酒精中毒研究学会年度科学会议上举办的一次研讨会的会议记录。组织者和联合主席是医学博士、哲学博士班科勒·A·约翰逊和医学博士、哲学博士罗伯特·M·斯威夫特。演讲内容包括：（1）班科勒·A·约翰逊的引言；（2）乔瓦尼·阿多拉托的《γ-羟基丁酸和巴氯芬治疗酒精成瘾的安全性、耐受性和疗效》；（3）休·迈里克的《加巴喷丁治疗酒精中毒的安全性》；（4）班科勒·A·约翰逊的《托吡酯治疗酒精依赖安全性和有效性的新数据》；（5）多梅尼克·A·西拉洛的《评估向酒精依赖个体开具苯二氮䓬类药物的风险》；以及（6）罗伯特·M·斯威夫特的《GABA能药物治疗酗酒者的安全性和有效性：讨论》。
